chemotherapy

Open Access
Dynamic Changes in Peripheral Systemic Immunity Markers During Chemotherapy in HER2-negative Advanced Breast Cancer
TAKAAKI MASUDA, HIROAKI UEO, YUTA OKUMURA, YUICHIRO KAI, YUKI ANDO, KEN MASUGUCHI, MIWA KITAGAWA, AKIHIRO KITAGAWA, NAOKI HAYASHI, YUSUKE TSURUDA, YUICHI HISAMATSU, SHUJI SUEHIRO, HIROFUMI OHMURA, KENJI FUJIYOSHI, FUMIAKI TANAKA and KOSHI MIMORI

Cancer Genomics & Proteomics March 2023, 20 (2) 182-194; DOI: https://doi.org/10.21873/cgp.20373
Open Access
Biomarker Expression Profiling in Cervix Carcinoma Biopsies Unravels WT1 as a Target of Artesunate
MOHAMED E. M. SAEED, CANDELA CIVES-LOSADA and THOMAS EFFERTH

Cancer Genomics & Proteomics November 2022, 19 (6) 727-739; DOI: https://doi.org/10.21873/cgp.20355
Open Access
SLFN12 Over-expression Sensitizes Triple Negative Breast Cancer Cells to Chemotherapy Drugs and Radiotherapy
AHMED ADHAM RAAFAT ELSAYED, SARMAD AL-MARSOUMMI, EMILIE E. VOMHOF-DEKREY and MARC D. BASSON

Cancer Genomics & Proteomics May 2022, 19 (3) 328-338; DOI: https://doi.org/10.21873/cgp.20323
You have access
Therapy-induced Deletion in 11q23 Leading to Fusion of KMT2A With ARHGEF12 and Development of B Lineage Acute Lymphoplastic Leukemia in a Child Treated for Acute Myeloid Leukemia Caused by t(9;11)(p21;q23)/KMT2A-MLLT3
IOANNIS PANAGOPOULOS, KRISTIN ANDERSEN, MARTINE EILERT-OLSEN, BERNWARD ZELLER, MONICA CHENG MUNTHE-KAAS, JOCHEN BUECHNER, LIV T.N. OSNES, FRANCESCA MICCI and SVERRE HEIM

Cancer Genomics & Proteomics January 2021, 18 (1) 67-81; DOI: https://doi.org/10.21873/cgp.20242
Open Access
Association of miR-125b, miR-17 and let-7c Dysregulations With Response to Anti-epidermal Growth Factor Receptor Monoclonal Antibodies in Patients With Metastatic Colorectal Cancer
ONDREJ FIALA, ONDREJ SOREJS, PETR HOSEK, VACLAV LISKA, ONDREJ VYCITAL, JAN BRUHA, RADEK KUCERA, ONDREJ TOPOLCAN, JINDRICH FINEK, DIANA MACECKOVA and PAVEL PITULE

Cancer Genomics & Proteomics September 2020, 17 (5) 605-613; DOI: https://doi.org/10.21873/cgp.20217
Open Access
ILK Expression in Colorectal Cancer Is Associated with EMT, Cancer Stem Cell Markers and Chemoresistance
DIMITRIOS TSOUMAS, SOFIA NIKOU, EFSTATHIA GIANNOPOULOU, SPYRIDON CHAMPERIS TSANIRAS, CHAIDO SIRINIAN, IOANNIS MAROULIS, STAVROS TARAVIRAS, VASSILIKI ZOLOTA, HARALABOS P. KALOFONOS and VASILIKI BRAVOU

Cancer Genomics & Proteomics March 2018, 15 (2) 127-141;
Open Access
Doxorubicin Affects Expression of Proteins of Neuronal Pathways in MCF-7 Breast Cancer Cells
MARIAN PETROVIC, CEDRIC SIMILLION, PETER KRUZLIAK, JAN SABO and MANFRED HELLER

Cancer Genomics & Proteomics November 2015, 12 (6) 347-358;

Main menu

User menu

Search

chemotherapy